chr3-41465961-C-G
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_017886.4(ULK4):c.3227-2708G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.325 in 151,916 control chromosomes in the GnomAD database, including 9,181 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.33   (  9181   hom.,  cov: 32) 
Consequence
 ULK4
NM_017886.4 intron
NM_017886.4 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  -1.04  
Publications
2 publications found 
Genes affected
 ULK4  (HGNC:15784):  (unc-51 like kinase 4) This gene encodes a member of the unc-51-like serine/threonine kinase (STK) family. Members of this protein family play a role in neuronal growth and endocytosis. The encoded protein is likely involved in neurite branching, neurite elongation and neuronal migration. Genome-wide association studies (GWAS) indicate an association of variations in this gene with blood pressure and hypertension. Sequence variations in this gene may also be be associated with psychiatric disorders, including schizophrenia and bipolar disorder. Pseudogenes associated with this gene have been identified and are located on chromosome 15. [provided by RefSeq, Jul 2016] 
ULK4 Gene-Disease associations (from GenCC):
- prostate cancerInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.98). 
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.504  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.325  AC: 49359AN: 151796Hom.:  9156  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
49359
AN: 
151796
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome  0.325  AC: 49415AN: 151916Hom.:  9181  Cov.: 32 AF XY:  0.320  AC XY: 23761AN XY: 74226 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
49415
AN: 
151916
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
23761
AN XY: 
74226
show subpopulations 
African (AFR) 
 AF: 
AC: 
21127
AN: 
41426
American (AMR) 
 AF: 
AC: 
3204
AN: 
15256
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
967
AN: 
3468
East Asian (EAS) 
 AF: 
AC: 
655
AN: 
5174
South Asian (SAS) 
 AF: 
AC: 
1774
AN: 
4808
European-Finnish (FIN) 
 AF: 
AC: 
2656
AN: 
10540
Middle Eastern (MID) 
 AF: 
AC: 
96
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
17929
AN: 
67932
Other (OTH) 
 AF: 
AC: 
658
AN: 
2106
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.502 
Heterozygous variant carriers
 0 
 1598 
 3196 
 4795 
 6393 
 7991 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 484 
 968 
 1452 
 1936 
 2420 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
946
AN: 
3478
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.